These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 18630520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
    Cui R, Takahashi F, Ohashi R, Yoshioka M, Gu T, Tajima K, Unnoura T, Iwakami S, Hirama M, Ishiwata T, Iwase A, Takahashi K.
    Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
    Yeh HH, Lai WW, Chen HH, Liu HS, Su WC.
    Oncogene; 2006 Jul 20; 25(31):4300-9. PubMed ID: 16518408
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Hsu IL, Su WC, Yan JJ, Chang JM, Lai WW.
    Lung Cancer; 2009 Sep 20; 65(3):371-6. PubMed ID: 19157636
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
    Puri N, Khramtsov A, Ahmed S, Nallasura V, Hetzel JT, Jagadeeswaran R, Karczmar G, Salgia R.
    Cancer Res; 2007 Apr 15; 67(8):3529-34. PubMed ID: 17440059
    [Abstract] [Full Text] [Related]

  • 9. A sulindac analogue is effective against malignant pleural effusion in mice.
    Moschos C, Psallidas I, Cottin T, Kollintza A, Papiris S, Roussos C, Stathopoulos GT, Giannis A, Kalomenidis I.
    Lung Cancer; 2011 Aug 15; 73(2):171-5. PubMed ID: 21227533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
    Zarogoulidis P, Chatzaki E, Hohenforst-Schmidt W, Goldberg EP, Galaktidou G, Kontakiotis T, Karamanos N, Zarogoulidis K.
    Cancer Gene Ther; 2012 Sep 15; 19(9):593-600. PubMed ID: 22744209
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q, Zhan P, Sun WK, Zhang Y, Song Y, Yu LK.
    Neoplasma; 2012 Sep 15; 59(4):433-9. PubMed ID: 22489699
    [Abstract] [Full Text] [Related]

  • 14. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z.
    Clin Cancer Res; 2008 Oct 15; 14(20):6432-9. PubMed ID: 18927282
    [Abstract] [Full Text] [Related]

  • 15. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M, Tamiya A, Yasue T, Nakao K, Omachi N, Shiroyama T, Tani E, Hamaguchi M, Morishita N, Suzuki H, Okamoto N, Okishio K, Kawaguchi T, Atagi S, Hirashima T.
    Anticancer Res; 2016 Jun 15; 36(6):2939-44. PubMed ID: 27272808
    [Abstract] [Full Text] [Related]

  • 16. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
    Magkouta S, Pappas A, Moschos C, Vazakidou ME, Psarra K, Kalomenidis I.
    Oncotarget; 2016 Apr 12; 7(15):20249-59. PubMed ID: 26959120
    [Abstract] [Full Text] [Related]

  • 17. Zoledronic acid is effective against experimental malignant pleural effusion.
    Stathopoulos GT, Moschos C, Loutrari H, Kollintza A, Psallidas I, Karabela S, Magkouta S, Zhou Z, Papiris SA, Roussos C, Kalomenidis I.
    Am J Respir Crit Care Med; 2008 Jul 01; 178(1):50-9. PubMed ID: 18388351
    [Abstract] [Full Text] [Related]

  • 18. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
    Psallidas I, Stathopoulos GT, Maniatis NA, Magkouta S, Moschos C, Karabela SP, Kollintza A, Simoes DC, Kardara M, Vassiliou S, Papiris SA, Roussos C, Kalomenidis I.
    Oncogene; 2013 Jan 24; 32(4):528-35. PubMed ID: 22370646
    [Abstract] [Full Text] [Related]

  • 19. Single cell phospho-specific flow cytometry can detect dynamic changes of phospho-Stat1 level in lung cancer cells.
    Lin CC, Huang WL, Su WP, Chen HH, Lai WW, Yan JJ, Su WC.
    Cytometry A; 2010 Nov 24; 77(11):1008-19. PubMed ID: 20814891
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.